Skip to main content

Disk Herniated Lumbar

0
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Quanta Therapeutics
Quanta TherapeuticsCA - South SF
1 program
Insertion of INTRASPINE deviceN/A1 trial
Active Trials
NCT03752671Completed199Est. Feb 2024
Spine BioPharma
Spine BioPharmaNY - New York
1 program
No referral for rehabilitationN/A1 trial
Active Trials
NCT03505918Completed146Est. Sep 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Quanta TherapeuticsInsertion of INTRASPINE device
Spine BioPharmaNo referral for rehabilitation

Clinical Trials (2)

Total enrollment: 345 patients across 2 trials

NCT03752671Quanta TherapeuticsInsertion of INTRASPINE device

Efficacy and Safety of IntraSPINE® Associated With Discectomy in the Treatment of Lumbar Disc Herniation.

Start: May 2019Est. completion: Feb 2024199 patients
N/ACompleted
NCT03505918Spine BioPharmaNo referral for rehabilitation

Supervised Physical Therapy Versus Unsupervised Home Exercise After Surgery for Lumbar Disc Herniation

Start: Oct 2015Est. completion: Sep 2019146 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.